Giovanna C.
- Country
- France
- Department
- N/A
Research Overview
- Evaluation of Etavopivat, a Pyruvate Kinase Activator, in a Randomized, Placebo-Controlled Study for Sickle Cell Disease in Patients Aged 12 to 65 Years
- Efficacy and Safety Evaluation of Oral Decitabine-Tetrahydrouridine in Hydroxyurea-Non-Eligible Sickle Cell Disease Patients
- Long-term Safety and Efficacy Evaluation of Etavopivat in Patients with Sickle Cell Disease or Thalassaemia Transitioning from Previous Etavopivat Studies
Data & Insights
Has run more than one trial at 46 of 77 partner sites.
Specializations
Hematological Disorders
This investigator specializes in treating sickle cell disease (SCD) and its various manifestations, with particular attention to nephropathy and acute chest syndrome complications.
- SCD Management
- Renal Complications
- Respiratory Support Therapies
Their work extends to evaluating novel therapeutic approaches for SCD-related organ damage.
Thalassemia Research
The investigator focuses on both transfusion-dependent and non-transfusion-dependent thalassemia, investigating innovative treatments for alpha and beta variants.
- Anemia Management
- Transfusion Burden Reduction
- Novel Therapeutic Approaches
Their expertise encompasses comprehensive care strategies for thalassemia patients.
Crisis Management
The investigator specializes in treating acute complications including vaso-occlusive crisis (VOC) in SCD patients, developing interventions for crisis resolution.
- Emergency Care Protocols
- Pain Management
- Crisis Prevention Strategies
Their research aims to improve outcomes during acute disease manifestations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.